Cidara Therapeutics surged 250% on strong CD388 trial results and solid financials, but faces Phase 3 challenges ahead. See ...

Technologies with the greatest potential for Poland include advanced materials, quantum communication, and biotechnologies ...

In the United States, health mandates traditionally have been tempered by the need to allow people to make personal choices.

Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

Beijing-based biotech unicorn METiS TechBio has rolled out what it calls the world's first AI-powered nano-delivery platform, ...

Agencies and communications professionals involved in the healthcare sector have a golden opportunity to leverage our ...

Moderna, Inc. (NASDAQ:MRNA) is the ill-fated vaccine company that has continued to struggle after the COVID-19 pandemic’s end ...

A rare display of bipartisan consensus at Robert F. Kennedy Jr’s Senate hearing. The latest jobs report is expected to show a slowdown in the workforce. And the NFL returns with a shocking ejection ...

On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...

The United States recently took a dangerous step backward in its pursuit of lifesaving cures and pandemic preparedness. The Department of Health and Human Services shut down 22 federally funded mRNA ...